Petros Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Petros Pharmaceuticals, a leader in men's health therapeutics, announces that President Fady Boctor will present at the H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Petros Pharmaceuticals, a leader in men's health therapeutics, announces that President Fady Boctor will present at the H.C. Wainwright Global Investment Conference from September 13-15, 2021. The presentation will be accessible starting at 7:00 AM ET on September 13. Additionally, Mr. Boctor will hold one-on-one meetings throughout the event. Petros Pharmaceuticals aims to be a top specialized men's health company focusing on issues like erectile dysfunction, Peyronie's disease, and hormone health.
Details
News Market Reaction – PTPI
The recorded move for PTPI in the trading session of this news was +3.48%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Sept. 10, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, announces today that President and Chief Commercial Officer Fady Boctor will present at the H.C. Wainwright Global Investment Conference, which is being held virtually from September 13 – 15, 2021.
Mr. Boctor will deliver his corporate presentation, which will become available beginning on September 13 at 7:00 AM ET.
Investors can register here: www.hcwevents.com.
Mr. Boctor will also be available for one-on-one meetings throughout the conference.
About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.
View original content:https://www.prnewswire.com/news-releases/petros-pharmaceuticals-to-present-at-the-hc-wainwright-23rd-annual-global-investment-conference-301373094.html
SOURCE Petros Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.